Electroceuticals/Bioelectric Medicine Market - Global Forecast to 2021

  • ID: 3765975
  • Report
  • Region: Global
  • 219 Pages
  • Markets and Markets
1 of 4
The Global Electroceuticals/Bioelectric Medicine Market is Expected to Reach USD 25.20 Billion by 2021 from USD 17.20 Billion in 2016, Growing at a CAGR of 7.9% from 2016 to 2021

FEATURED COMPANIES

  • Biotronik
  • Cochlear Limited
  • Electrocore LLC
  • Livanova PLC
  • Medtronic PLC
  • Nevro Corp.
  • MORE
"Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) - Global Forecast to 2021"

Electroceuticals are medical devices that use electrical impulses to modulate the body's neural circuits as an alternative to drug-based interventions. These electroceutical devices read and modify electrical signals passing along the nerves of the body, including irregular or altered impulses that can occur in association with a broad range of diseases.

The implantable cardioverter defibrillators segment is expected to account for the largest share of the electroceuticals/bioelectric medicine market, by product, in 2016. Increasing sudden cardiac arrest (SCA) leading to cardiovascular death, technological advancements in ICDs, and increasing arrhythmia is contributing to the large share of this segment.

The implantable electroceutical devices segment is expected to account for the largest share of the electroceuticals/bioelectric medicine market, by type of device, in 2016. The rising research in this industry and collaborations and partnerships to development electroceutical devices, these devices providing continuous treatment within the body, and providing an environment for the easy treatment of patients is driving growth in this market segment. The hospitals segment is estimated to account for the largest share of the electroceuticals/bioelectric medicine market, by end user, in 2016. This can be attributed to increasing burden of diseases such as cardiac arrhythmias, Parkinson’s, Alzheimer’s, retinitis pigmentosa, epilepsy, and depression; and increasing awareness about electroceuticals.

North America is expected to account for the largest share of the global electroceuticals/bioelectric medicine market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American region can be attributed to the rising prevalence of arrhythmia, growing prevalence of chronic diseases, expected approvals for retinal implants, increasing regulatory approvals in the U.S., increasing burden of cancer and diabetes, and increase in hearing loss owing to rising aging population in Canada, among others.

The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the rising adoption of neurostimulation, increasing cases of diabetes, increasing prevalence of hearing loss, increasing geriatric population, conferences on electroceutical devices, increasing prevalence of Parkinson’s Disease, and regulatory approvals of cochlear implants in the Asia-Pacific region.

The electroceuticals/bioelectric medicine market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, approvals, new product launches, agreements/collaborations/joint ventures/partnerships, marketing and promotion activities, acquisitions and mergers, expansions, market developments, new program launches, and product enhancements) to increase their market shares and establish a stronger foothold in the global market.

Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Limited (Australia), Sonova Holding AG (Switzerland), LivaNova PLC (U.K.), Biotronik (Germany), Nevro Corporation (U.S.), Second Sight Medical Products, Inc. (U.S.), and ElectroCore LLC (U.S.) are the key players in the global electroceuticals/bioelectric medicine market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios of the top players in the medical animation market. The report analyzes the market based on product, type of device, application, and end user

- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the electroceuticals/bioelectric medicine market

- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various electroceuticals/bioelectric medicines across regions

- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the electroceuticals/bioelectric medicine market

- Competitive Assessment: In-depth assessment of strategies, products, distribution networks, and manufacturing capabilities of the leading players in the electroceuticals/bioelectric medicine market
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Biotronik
  • Cochlear Limited
  • Electrocore LLC
  • Livanova PLC
  • Medtronic PLC
  • Nevro Corp.
  • MORE
1 Introduction
1.1 Objectives of Study
1.2 Electroceuticals Market Definition
1.3 Electroceuticals Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Key Industry Insights
2.3 Key Data From Primary Sources
2.4 Key Insights From Primary Sources
2.5 Electroceuticals Market Size Estimation Methodology
2.6 Research Design
2.7 Electroceuticals Market Data Validation and Triangulation
2.8 Assumptions for the Study

3 Executive Summary (Page No. - 35)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook

4 Premium Insights
4.1 Global Electroceuticals Market
4.2 Global Electroceuticals Market, By Product
4.3 Global Electroceuticals Market, By Region and Deep Brain Stimulation Applications
4.4 Global Electroceuticals Market, By Region
4.5 Global Electroceuticals Market, By End User (2016 vs. 2021)

5 Market Overview
5.1 Introduction
5.2 Electroceuticals Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Geriatric Population
5.2.1.2 Regulatory Approval for New and Advanced Electroceuticals
5.2.1.3 Growing Investments and Funds for the Development of Novel Therapies and Electroceuticals
5.2.1.4 Rising Prevalence of Neurological Disorders
5.2.1.5 Growing Prevalence of Hearing Loss
5.2.2 Restraints
5.2.2.1 Lack of Skilled Professionals
5.2.2.2 High Cost of Cochlear Implants
5.2.3 Opportunities
5.2.3.1 Growth Potential Offered By Emerging Countries
5.2.3.2 Strong Product Pipeline
5.2.4 Challenges
5.2.4.1 Unfavorable Reimbursement Scenario

6 Global Electroceuticals Market, By Product
6.1 Introduction
6.2 Implantable Cardioverter Defibrillators
6.3 Cardiac Pacemakers
6.4 Spinal Cord Stimulators
6.5 Cochlear Implants
6.6 Deep Brain Stimulators
6.7 Transcutaneous Electrical Nerve Stimulators
6.8 Vagus Nerve Stimulators
6.9 Sacral Nerve Stimulators
6.10 Retinal Implants
6.11 Other Electrical Stimulators

7 Global Electroceuticals Market, By Type of Device
7.1 Introduction
7.2 Implantable Electroceutical Devices
7.3 Non-Invasive Electroceutical Devices

8 Global Electroceuticals Market, By Application
8.1 Introduction
8.2 Cardiac Pacemakers and Implantable Cardioverter Defibrillators Market, By Application
8.2.1 Arrhythmia
8.3 Spinal Cord Stimulators (SCS) Market, By Application
8.3.1 Chronic Pain
8.3.2 Failed Back Syndrome (FBSS)
8.3.3 Ischemia
8.4 Cochlear Implants Market, By Application
8.4.1 Sensorineural Hearing Loss
8.5 Deep Brain Stimulators (DBS) Market, By Application
8.5.1 Parkinson’s Disease
8.5.2 Tremor
8.5.3 Depression
8.5.4 Other Deep Brain Stimulation Applications
8.6 Transcutaneous Electrical Nerve Stimulators (RENS) Market, By Application
8.6.1 Treatment-Resistant Depression
8.6.2 Other Transcutaneous Electrical Stimulation Applications
8.7 Vagus Nerve Stimulators Market (VNS), By Application
8.7.1 Epilepsy
8.7.2 Other Vagus Nerve Stimulation Applications
8.8 Sacral Nerve Stimulators (SNS) Market, By Application
8.8.1 Urinary Incontinence
8.8.2 Fecal Incontinence
8.9 Retinal Implants Market, By Application
8.9.1 Retinitis Pigmentosa
8.10 Other Electrical Stimulators Market, By Application
8.10.1 Gastroparesis
8.10.2 Obesity
8.10.3 Depression
8.10.4 Migraine
8.10.5 Spinal Cord Injury

9 Global Electroceuticals Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Research Institutes
9.4 Individual Users

10 Global Electroceuticals Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Rising Prevalence of Arrhythmia in the U.S.
10.2.1.2 Rising Prevalence of Chronic Diseases in the U.S.
10.2.1.3 High Prevalence of Hearing Loss in the U.S.
10.2.1.4 Rising Incidence of Rp Driving the Demand for Retinal Implants
10.2.1.5 Conferences & Annual Meetings
10.2.1.6 Increasing Regulatory Approvals in the U.S.
10.2.2 Canada
10.2.2.1 Growing Burden of Cancer and Diabetes in Canada
10.2.2.2 Increase in Hearing Loss, Owing to Rising Aging Population
10.3 Europe
10.3.1 Rapidly Aging Population in Europe
10.3.2 Conferences & Annual Meetings
10.3.3 Government Support for Hearing Implants
10.3.4 Rising Prevalence of Neurological Diseases in Germany and France
10.3.5 Rising Prevalence of Diabetes in the U.K. and Rest of Europe
10.3.6 Increasing Regulatory Approvals in Europe
10.4 Asia-Pacific
10.4.1 Rising Aging Population Driving Increase in Disease Incidence in Japan
10.4.2 Increasing Prevalence of Diabetes and Rapidly Aging Population in China
10.4.3 Increasing Prevalence of Hearing Loss in Asia-Pacific Region
10.4.4 Increasing Geriatric Population & High Diabetes Prevalence in India
10.4.5 Conferences on Electroceutical Devices in Apac
10.4.6 Increasing Prevalence of Parkinson’s Disease in Singapore
10.5 Rest of World
10.5.1 Rise in Aging Population & Prevalence of Diabetes in the Middle East and Africa
10.5.2 Conferences on Electroceutical Devices in Latin America and Africa
10.5.3 Growing Cases of Cancer in Latin America

11 Competitive Landscape
11.1 Overview
11.2 Competitive Situation and Trends
11.2.1 Introduction
11.2.2 Product Launches
11.2.3 Approvals
11.2.4 New Product Launches
11.2.5 Agreements, Collaborations, Joint Ventures, and Partnerships
11.2.6 Marketing and Promotion Activities
11.2.7 Acquisitions and Mergers
11.2.8 Expansions
11.2.9 Other Strategies
11.3 Global Electroceuticals Market: Empirical Assessment of Growth Strategies
11.3.1 Route to Strategic Growth: Organic and Inorganic Growth Strategies
11.3.2 Organic Growth Strategies
11.3.3 Inorganic Growth Strategies

12 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, Mnm View)*
12.1 Introduction
12.2 Medtronic PLC
12.3 St. Jude Medical, Inc.
12.4 Boston Scientific Corporation
12.5 Cochlear Limited
12.6 Sonova Holding AG
12.7 Livanova PLC
12.8 Biotronik
12.9 Nevro Corp.
12.10 Second Sight Medical Products, Inc.
12.11 Electrocore LLC

13 Appendix
13.1 Discussion Guide

List of Tables

Table 1 Prevalence of Hearing Loss, By Region, 2012 (Million)
Table 2 Growing Investments and Funds for the Development of Novel Therapies and Electroceuticals Driving Market Growth
Table 3 Lack of Skilled Professionals Restraining Market Growth
Table 4 Emerging Countries to Offer Significant Growth Opportunities to Market Players
Table 5 Unfavorable Reimbursement Scenario is A Major Challenge in the Market
Table 6 Global Electroceuticals Market Size, By Product,2014-2021 (USD Million)
Table 7 Global Implantable Cardioverter Defibrillators Market Size,By Region, 2014-2021 (USD Million)
Table 8 North America: Implantable Cardioverter Defibrillators Market Size, By Country, 2014-2021 (USD Million)
Table 9 Global Cardiac Pacemakers Market Size, By Region,2014-2021 (USD Million)
Table 10 North America: Cardiac Pacemakers Market Size, By Country,2014-2021 (USD Million)
Table 11 Global Spinal Cord Stimulators Market Size, By Region,2014-2021 (USD Million)
Table 12 North America: Spinal Cord Stimulators Market Size, By Country,2014-2021 (USD Million)
Table 13 Global Cochlear Implant Market Size, By Region,2014-2021 (USD Million)
Table 14 North America: Cochlear Implant Market Size, By Country,2014-2021 (USD Million)
Table 15 Global Deep Brain Stimulators Market Size, By Region,2014-2021 (USD Million)
Table 16 North America: Deep Brain Stimulators Market Size, By Country,2014-2021 (USD Million)
Table 17 Global Transcutaneous Electrical Nerve Stimulators Market Size,By Region, 2014-2021 (USD Million)
Table 18 North America: Transcutaneous Electrical Nerve Stimulators Market Size, By Country, 2014-2021 (USD Million)
Table 19 Global Vagus Nerve Stimulators Market Size, By Region,2014-2021 (USD Million)
Table 20 North America: Vagus Nerve Stimulators Market Size, By Country,2014-2021 (USD Million)
Table 21 Global Sacral Nerve Stimulators Market Size, By Region,2014-2021 (USD Million)
Table 22 North America: Sacral Nerve Stimulators Market Size,By Country, 2014-2021 (USD Million)
Table 23 Global Retinal Implants Market Size, By Region,2014-2021 (USD Million)*
Table 24 North America: Retinal Implants Market Size, By Country,2014-2021 (USD Million)
Table 25 Global Other Electrical Stimulators Market Size, By Region,2014-2021 (USD Million)
Table 26 North America: Other Electrical Stimulators Market Size, By Country, 2014-2021 (USD Million)
Table 27 Global Electroceuticals Market Size, By Type of Device,2014-2021 (USD Million)
Table 28 Global Implantable Electroceutical Devices Market Size, By Region, 2014-2021 (USD Million)
Table 29 North America: Implantable Electroceutical Devices Market Size,By Country, 2014-2021 (USD Million)
Table 30 Global Non-Invasive Electroceutical Devices Market Size, By Region, 2014-2021 (USD Million)
Table 31 North America: Non-Invasive Electroceutical Devices Market Size,By Country, 2014-2021 (USD Million)
Table 32 Global Spinal Cord Stimulators Market Size, By Application,2014-2021 (USD Million)
Table 33 Global Spinal Cord Stimulators Application Market Size for Chronic Pain, By Region, 2014-2021 (USD Million)
Table 34 North America: Spinal Cord Stimulators Application Market Size for Chronic Pain, By Country, 2014-2021 (USD Million)
Table 35 Global Spinal Cord Stimulators Application Market Size for Failed Back Surgery Syndrome, By Region, 2014-2021 (USD Million)
Table 36 North America: Spinal Cord Stimulators Application Market Size for Failed Back Surgery Syndrome, By Country, 2014-2021 (USD Million)
Table 37 Global Spinal Cord Stimulators Application Market Size for Ischemia, By Region, 2014-2021 (USD Million)
Table 38 North America: Spinal Cord Stimulators Application Market Size for Ischemia, By Country, 2014-2021 (USD Million)
Table 39 Global Deep Brain Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 40 Global Deep Brain Stimulators Application Market Size for Parkinson’s Disease, By Region, 2014-2021 (USD Million)
Table 41 North America: Deep Brain Stimulators Application Market Size for Parkinson’s Disease, By Country, 2014-2021 (USD Million)
Table 42 Global Deep Brain Stimulators Application Market Size for Tremors, By Region, 2014-2021 (USD Million)
Table 43 North America: Deep Brain Stimulators Application Market Size for Tremors, By Country, 2014-2021 (USD Million)
Table 44 Global Deep Brain Stimulators Application Market Size for Depression, By Region, 2014-2021 (USD Million)
Table 45 North America: Deep Brain Stimulators Application Market Size for Depression, By Country, 2014-2021 (USD Million)
Table 46 Global Deep Brain Stimulators Application Market Size for Other Deep Brain Stimulation Applications, By Region, 2014-2021 (USD Million)
Table 47 North America: Deep Brain Stimulators Application Market Size for Other Deep Brain Stimulation Applications, By Country,2014-2021 (USD Million)
Table 48 Global Transcutaneous Electrical Nerve Stimulation Market Size,By Application, 2014-2021 (USD Million)
Table 49 Global Transcutaneous Electrical Nerve Stimulators Application Market Size for Treatment-Resistant Depression, By Region,2014-2021 (USD Million)
Table 50 North America: Transcutaneous Electrical Nerve Stimulators Application Market Size for Treatment-Resistant Depression, By Country, 2014-2021 (USD Million)
Table 51 Global Transcutaneous Electrical Nerve Stimulators Application Market Size for Other Transcutaneous Electrical Stimulation Applications, By Region, 2014-2021 (USD Million)
Table 52 North America: Transcutaneous Electrical Nerve Stimulators Application Market Size for Other Transcutaneous Electrical Stimulation Applications, By Country, 2014-2021 (USD Million)
Table 53 Global Vagus Nerve Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 54 Global Vagus Nerve Stimulators Application Market Size for Epilepsy, By Region, 2014-2021 (USD Million)
Table 55 North America: Vagus Nerve Stimulators Application Market Size for Epilepsy, By Country, 2014-2021 (USD Million)
Table 56 Global Vagus Nerve Stimulators Application Market Size for Other Vagus Nerve Stimulation Applications, By Region,2014-2021 (USD Million)
Table 57 North America: Vagus Nerve Stimulators Application Market Size for Other Vagus Nerve Stimulation Applications, By Country,2014-2021 (USD Million)
Table 58 Global Sacral Nerve Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 59 Global Sacral Nerve Stimulators Application Market Size for Urinary Incontinence, By Region, 2014-2021 (USD Million)
Table 60 North America: Sacral Nerve Stimulators Application Market Size for Urinary Incontinence, By Country, 2014-2021 (USD Million)
Table 61 Global Sacral Nerve Stimulators Application Market Size for Fecal Incontinence, By Region, 2014-2021 (USD Million)
Table 62 North America: Sacral Nerve Stimulators Application Market Size for Fecal Incontinence, By Country, 2014-2021 (USD Million)
Table 63 Global Other Electrical Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 64 Global Other Electrical Stimulators Application Market Size for Gastroparesis, By Region, 2014-2021 (USD Million)
Table 65 North America: Other Electrical Stimulators Application Market Size for Gastroparesis, By Country, 2014-2021 (USD Million)
Table 66 Global Other Electrical Stimulators Application Market Size for Obesity, By Region, 2014-2021 (USD Million)
Table 67 North America: Other Electrical Stimulators Application Market Size for Obesity, By Country, 2014-2021 (USD Million)
Table 68 Global Other Electrical Stimulators Application Market Size for Depression, By Region, 2014-2021 (USD Million)
Table 69 North America: Other Electrical Stimulators Application Market Size for Depression, By Country, 2014-2021 (USD Million)
Table 70 Global Other Electrical Stimulators Application Market Size for Migraine, By Region, 2014-2021 (USD Million)
Table 71 North America: Other Electrical Stimulators Application Market Size for Migraine, By Country, 2014-2021 (USD Million)
Table 72 Global Other Electrical Stimulators Application Market Size for Spinal Cord Injury, By Region, 2014-2021 (USD Million)
Table 73 North America: Other Electrical Stimulators Application Market Size for Spinal Cord Injury, By Country, 2014-2021 (USD Million)
Table 74 Global Electroceuticals Market Size, By End User,2014 - 2021 (USD Million)
Table 75 Global Electroceuticals Market Size for Hospitals, By Region,2014 - 2021 (USD Million)
Table 76 North America: Electroceuticals Market Size for Hospitals,By Country, 2014 - 2021 (USD Million)
Table 77 Global Electroceuticals Market Size for Research Institutes,By Region, 2014 - 2021 (USD Million)
Table 78 North America: Electroceuticals Market Size for Research Institutes, By Country, 2014 - 2021 (USD Million)
Table 79 Global Electroceuticals Market Size for Individual Users, By Region, 2014 - 2021 (USD Million)
Table 80 North America: Electroceuticals Market Size for Individual Users,By Country, 2014 - 2021 (USD Million)
Table 81 Global Electroceuticals Market Size, By Region,2014-2021 (USD Million)
Table 82 North America: Electroceuticals Market Size, By Country,2014-2021 (USD Million)
Table 83 North America: Electroceuticals Market Size, By Product,2014-2021 (USD Million)
Table 84 North America: Electroceuticals Market Size, By Type of Device,2014-2021 (USD Million)
Table 85 North America: Spinal Cord Stimulation Market Size, By Application, 2014-2021 (USD Million)
Table 86 North America: Deep Brain Stimulation Market Size, By Application, 2014-2021 (USD Million)
Table 87 North America: Transcutaneous Electrical Nerve Stimulation Market Size, By Application, 2014-2021 (USD Million)
Table 88 North America: Vagus Nerve Stimulation Market Size, By Application, 2014-2021 (USD Million)
Table 89 North America: Sacral Nerve Stimulation Market Size, By Application, 2014-2021 (USD Million)
Table 90 North America: Other Electrical Stimulation Market Size,By Application, 2014-2021 (USD Million)
Table 91 North America: Electroceuticals Market Size, By End User,2014-2021 (USD Million)
Table 92 U.S.: Electroceuticals Market Size, By Product, 2014-2021 (USD Million)
Table 93 U.S.: Electroceuticals Market Size, By Type of Device,2014-2021 (USD Million)
Table 94 U.S.: Spinal Cord Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 95 U.S.: Deep Brain Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 96 U.S.: Transcutaneous Electrical Nerve Stimulation Market Size,By Application, 2014-2021 (USD Million)
Table 97 U.S.: Vagus Nerve Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 98 U.S.: Sacral Nerve Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 99 U.S.: Other Electrical Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 100 U.S.: Electroceuticals Market Size, By End User, 2014-2021 (USD Million)
Table 101 Canada: Electroceuticals Market Size, By Product,2014-2021 (USD Million)
Table 102 Canada: Electroceuticals Market Size, By Type of Device,2014-2021 (USD Million)
Table 103 Canada: Spinal Cord Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 104 Canada: Deep Brain Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 105 Canada: Transcutaneous Electrical Nerve Stimulation Market Size,By Application, 2014-2021 (USD Million)
Table 106 Canada: Vagus Nerve Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 107 Canada: Sacral Nerve Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 108 Canada: Other Electrical Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 109 Canada: Electroceuticals Market Size, By End User,2014-2021 (USD Million)
Table 110 Europe: Electroceuticals Market Size, By Product,2014-2021 (USD Million)
Table 111 Europe: Electroceuticals Market Size, By Type of Device,2014-2021 (USD Million)
Table 112 Europe: Spinal Cord Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 113 Europe: Deep Brain Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 114 Europe: Transcutaneous Electrical Nerve Stimulation Market Size,By Application, 2014-2021 (USD Million)
Table 115 Europe: Vagus Nerve Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 116 Europe: Sacral Nerve Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 117 Europe: Other Electrical Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 118 Europe: Electroceuticals Market Size, By End User,2014-2021 (USD Million)
Table 119 Asia-Pacific: Electroceuticals Market Size, By Product,2014-2021 (USD Million)
Table 120 Asia-Pacific: Electroceuticals Market Size, By Type of Device,2014-2021 (USD Million)
Table 121 Asia-Pacific: Spinal Cord Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 122 Asia-Pacific: Deep Brain Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 123 Asia-Pacific: Transcutaneous Electrical Nerve Stimulation Market Size, By Application, 2014-2021 (USD Million)
Table 124 Asia-Pacific: Vagus Nerve Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 125 Asia-Pacific: Sacral Nerve Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 126 Asia-Pacific: Other Electrical Stimulation Market Size, By Application, 2014-2021 (USD Million)
Table 127 Asia-Pacific: Electroceuticals Market Size, By End User,2014-2021 (USD Million)
Table 128 RoW: Electroceuticals Market Size, By Product, 2014-2021 (USD Million)
Table 129 RoW: Electroceuticals Market Size, By Type of Device,2014-2021 (USD Million)
Table 130 RoW: Spinal Cord Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 131 RoW: Deep Brain Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 132 RoW: Transcutaneous Electrical Nerve Stimulation Market Size,By Application, 2014-2021 (USD Million)
Table 133 RoW: Vagus Nerve Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 134 RoW: Sacral Nerve Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 135 RoW: Other Electrical Stimulation Market Size, By Application,2014-2021 (USD Million)
Table 136 RoW: Electroceuticals Market Size, By End User,2014-2021 (USD Million)
Table 137 Product Launches, 2013 - 2016
Table 138 Approvals, 2013 - 2016
Table 139 New Product Launches, 2013 - 2016
Table 140 Agreements, Collaborations, Joint Ventures, and Partnerships,2013 - 2016
Table 141 Marketing and Promotion Activities, 2013 - 2016
Table 142 Acquisitions and Mergers, 2013 - 2016
Table 143 Expansions, 2013-2016
Table 144 Other Strategies, 2013-2016

List of Figures

Figure 1 Global Electroceuticals Market Segmentation
Figure 2 Global Electroceuticals Market: Research Methodology Steps
Figure 3 Key Data From Secondary Sources
Figure 4 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Global Electroceuticals Market
Figure 6 Market Size Estimation Methodology: Bottom-Up Approach for Cardiac Pacemakers and Implantable Cardioverter Defibrillators Market
Figure 7 Market Size Estimation Methodology: Bottom-Up Approach for Cochlear Implants Market
Figure 8 Market Size Estimation Methodology: Bottom-Up Approach for Retinal Implants Market
Figure 9 Market Size Estimation Methodology: Bottom-Up Approach for Neuromodulation Devices Market
Figure 10 Market Size Estimation Methodology: Bottom-Up Approach for the Global Electroceuticals Market
Figure 11 Market Size Estimation Methodology: Top-Down Approach
Figure 12 Research Design
Figure 13 Data Triangulation Methodology
Figure 14 Non-Invasive Electroceutical Devices Market to Witness High Growth Rate From 2016 to 2021
Figure 15 Implantable Cardioverter Defibrillators Segment to Command the Largest Share of the Electroceuticals Market, By Product, in 2016
Figure 16 Global Electroceuticals Market, By End User, 2016 - 2021
Figure 17 Geographical Snapshot of the Global Electroceuticals Market, 2016
Figure 18 Spinal Cord Stimulators Market Size, By Application,2016 vs. 2021 (USD Million)
Figure 19 Regulatory Approval for New and Advanced Electroceuticals to Drive Market Growth
Figure 20 Retinal Implants Segment to Witness the Highest Growth During the Forecast Period
Figure 21 North America is Expected to Dominate the Global Electroceuticals Market in 2016
Figure 22 Asia-Pacific to Witness the Highest Growth During the Forecast Period
Figure 23 Hospitals Segment to Command the Largest Market Share During the Forecast Period
Figure 24 Global Electroceuticals Market: Drivers, Restraints, Opportunities, & Challenges
Figure 25 Global Electroceuticals Market, By Product
Figure 26 Retinal Implants Segment to Grow at the Highest CAGR During the Forecast Period
Figure 27 Global Electroceuticals Market Segmentation, By Type of Device
Figure 28 Non-Invasive Electroceutical Devices Segment to Witness Highest CAGR of 23.3% During the Forecast Period
Figure 29 Global Electroceuticals Market, By Application
Figure 30 Global Electroceuticals Market Segmentation, By End User
Figure 31 Individual Users Segment to Witness the Highest Growth Rate in the Forecast Period
Figure 32 North America to Command the Largest Share of the Global Electroceuticals Market in 2016
Figure 33 North American Electroceuticals Market Snapshot
Figure 34 European Electroceuticals Market Snapshot
Figure 35 Asia-Pacific Electroceuticals Market Snapshot
Figure 36 RoW Electroceuticals Market Snapshot
Figure 37 Top 5 Strategies Adopted By Players Over the Last Three Years(2013 - 2016)
Figure 38 Battle for Market Share: Market Expansion Was the Key Strategy(2013 -2016)
Figure 39 Organic & Inorganic Growth Strategies: Industry Trend vs. Key Players
Figure 40 Organic Growth Strategies, By Key Player (2013 - 2016)
Figure 41 Inorganic Growth Strategies, By Key Player (2013 - 2016)
Figure 42 Product Mix of Key Players in the Market
Figure 43 Medtronic PLC: Company Snapshot
Figure 44 St. Jude Medical, Inc.: Company Snapshot
Figure 45 Boston Scientific Corporation: Company Snapshot
Figure 46 Cochlear Limited: Company Snapshot
Figure 47 Sonova Holding AG: Company Snapshot
Figure 48 Livanova PLC: Company Snapshot
Figure 49 Nevro Corp.: Company Snapshot
Figure 50 Second Sight Medical Products, Inc.: Company Snapshot
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Biotronik
  • Cochlear Limited
  • Electrocore LLC
  • Livanova PLC
  • Medtronic PLC
  • Nevro Corp.
  • MORE
The growth of the overall electroceuticals/bioelectric medicine market can be contributed to rising geriatric population, regulatory approval for new and advanced electroceuticals, growing investments and funds for the development of novel therapies and electroceuticals, rising prevalence of neurological disorders, and growing prevalence of hearing loss. However, lack of skilled professionals and high cost of cochlear implants is expected to restrain the growth of this market to a certain extent. Moreover, the growth potential offered by emerging countries and strong product pipeline are expected to provide growth opportunities for players operating in this market.

In this report, the electroceuticals/bioelectric medicine market has been segmented on the basis of product, type of device, application, and end user. On the basis of product, the electroceuticals/bioelectric medicine market is categorized into implantable cardioverter defibrillators, cardiac pacemakers, spinal cord stimulators, cochlear implants, deep brain stimulators, transcutaneous electrical nerve stimulators, vagus nerve stimulators, sacral nerve stimulators, retinal implants, and other electrical stimulators (gastric electrical stimulators, transcranial magnetic stimulators, and respiratory electrical stimulators). The implantable cardioverter defibrillators segment is expected to account for the largest share of the electroceuticals/bioelectric medicine market in 2016. Increase in sudden cardiac arrest (SCA) leading to cardiovascular death, technological advancements in ICDs, and increase in arrhythmia are factors contributing to the large share of this segment. The type of device segments described in the report include implantable electroceuticals devices, and non-invasive electroceuticals devices. The application segments described in the report are segmented into product wise such as cardiac pacemakers and implantable cardioverter defibrillators (used for arrhythmia), cochlear implants (used for sensorineural hearing loss), retinal implants (used for retinal pigmentosa), spinal cord stimulators (used for chronic pain, failed back surgery, and ischemia), deep brain stimulators (used for Parkinson's disease, tremors, depression, and others), sacral nerve stimulators (used for urine incontinence and fecal incontinence), vagus nerve stimulators (used for epilepsy and other conditions), transcutaneous electrical nerve stimulators (used for treatment-resistant depression and others), and other electric stimulators (used for gastro paresis, obesity, depression, migraine headaches, and spinal cord injuries). The end users listed in this report are hospitals, research institutes, and individual users.

In the coming years, North America is expected to account for the largest share of the electroceuticals/bioelectric medicine market. Factors such as rising prevalence of arrhythmia, growing prevalence of chronic diseases, high prevalence of hearing loss, expected approvals for retinal implants in the U.S., conferences & annual meetings held in the U.S., increasing regulatory approvals in the U.S., increasing burden of cancer and diabetes, and increase in hearing loss owing to rising aging population in Canada are contributing to the large share of the North American region. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. The high growth of this region can be attributed to the rising adoption of neurostimulation in Japan, increasing cases of diabetes and rapidly aging population in China, increasing prevalence of hearing loss in Asia-Pacific region, increasing geriatric population & high diabetes prevalence in India, conferences on electroceuticals devices in India and Australia, increasing prevalence of Parkinson’s Disease in Singapore, and regulatory approvals of cochlear implants in the Asia-Pacific region.

Major players in the electroceuticals/bioelectric medicine market include Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Limited (Australia), Sonova Holding AG (Switzerland), LivaNova PLC (U.K.), Biotronik (Germany), Nevro Corporation (U.S.), Second Sight Medical Products, Inc. (U.S.), and ElectroCore LLC (U.S.). Others are BioElectronics Corporation (U.S.), MED-EL (Austria), Cefaly Technology (Belgium), Stimwave LLC (U.S.), Vomaris Innovations, Inc. (U.S.), EnteroMedics Inc. (U.S.), NeuroSigma, Inc. (U.S.), and Oticon Medical (France).

Target Audience:

- Electroceuticals/Bioelectric Medicine Device Manufacturing Companies
- Suppliers and Distributors of Electroceuticals/Bioelectric Medicine Devices
- Healthcare Service Providers
- Teaching Hospitals and Academic Medical Centers (AMCs)
- Health Insurance Players
- Research and Consulting Firm
- Medical Research Institutes
- Audiology Centers
- Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
- Venture Capitalists
- Community Centers

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This research report categorizes the electroceuticals/bioelectric medicine market into the following segments:

Electroceuticals/Bioelectric Medicine Market, by Product

- Implantable Cardioverter Defibrillators
- Cardiac Pacemakers
- Spinal Cord Stimulators
- Cochlear Implants
- Deep Brain Stimulators
- Transcutaneous Electrical Nerve Stimulators
- Vagus Nerve Stimulators
- Sacral Nerve Stimulators
- Retinal Implants
- Other Electrical Stimulators

Electroceuticals/Bioelectric Medicine Market, by Type of Device

- Implantable Electroceuticals Devices
- Non-Invasive Electroceuticals Devices

Electroceuticals/Bioelectric Medicine Market, by Application

- Cardiac Pacemakers And Implantable Cardioverter Defibrillators Applications
- - Arrhythmia
- Spinal Cord Stimulators Applications
- - Chronic Pain
- - Failed Back Surgery
- - Ischemia
- Cochlear Implants Applications
- - Arrhythmia
- Deep Brain Stimulators Applications
- - Parkinson's Disease
- - Tremor
- - Depression
- - Other Deep Brain Stimulation Applications
- Transcutaneous Electrical Nerve Stimulators Applications
- - Treatment Resistant Depression
- - Other Transcutaneous Electrical Nerve Stimulator Applications
- Vagus Nerve Stimulators Applications
- - Epilepsy
- - Other Vagus Nerve Stimulation Applications
- Sacral Nerve Stimulators Applications
- - Urinary Incontinence
- - Fecal Incontinence
- Retinal Implants Applications
- - Retinitis Pigmentosa
- Other Electrical Stimulators Applications
- - Gastroparesis
- - Obesity
- - Depression
- - Migraine
- - Spinal Cord Injury

Electroceuticals Market, by End User

- Hospitals
- Research Institutes
- Individual Users

Electroceuticals Market, by Region

- North America
- - U.S.
- - Canada
- Europe
- Asia-Pacific
- Rest of the World (RoW)

The global electroceuticals/bioelectric medicine market is segmented on the basis of product, type of device, application, end user, and region. By product, the market is categorized into implantable cardioverter defibrillators, cardiac pacemakers, spinal cord stimulators, cochlear implants, deep brain stimulators, transcutaneous electrical nerve stimulators, vagus nerve stimulators, sacral nerve stimulators, retinal implants, and other electrical stimulators (gastric electrical stimulators, transcranial magnetic stimulators, and respiratory electrical stimulators). The implantable cardioverter defibrillators segment is expected to account for the largest share of the market in 2016. The largest share of this segment is mainly attributed to increase in sudden cardiac arrest (SCA) leading to cardiovascular death, technological advancements in ICDs, and increase in arrhythmia. However, the retinal implants segment is expected to grow at the highest CAGR during the forecast period (2016-2021).

The electroceuticals/bioelectric medicine market, based on type of device, is segmented into implantable electroceuticals devices, and non-invasive electroceuticals devices. The implantable electroceuticals devices segment is expected to account for the largest share of the market in 2016. This is mainly attributed to the rising research in this industry and collaborations and partnerships to development electroceuticals devices, the implantable electroceuticals devices being used since a long time, these devices providing continuous treatment within the body, and providing an environment for the easy treatment of patients. However, the non-invasive electroceuticals devices segment is expected to grow at the highest CAGR during the forecast period (2016-2021).

On basis of application, the market is segmented into product wise such as cardiac pacemakers and implantable cardioverter defibrillators (used for arrhythmia), cochlear implants (used for sensorineural hearing loss), retinal implants (used for retinal pigmentosa), spinal cord stimulators (used for chronic pain, failed back surgery, and ischemia), deep brain stimulators (used for Parkinson's disease, tremors, depression, and others), sacral nerve stimulators (used for urine incontinence and fecal incontinence), vagus nerve stimulators (used for epilepsy and other conditions), transcutaneous electrical nerve stimulators (used for treatment-resistant depression and others), and other electric stimulators (used for gastro paresis, obesity, depression, migraine headaches, and spinal cord injuries).

On the basis of end users, the electroceuticals/bioelectric medicine market is segmented into hospitals, research institutes, and individual users. The hospitals segment is expected to account for the largest share of the market in 2016. The large share of this segment can be attributed to the increasing burden of diseases such as cardiac arrhythmias, Parkinson’s, Alzheimer’s, retinitis pigmentosa, epilepsy, and depression; and increasing awareness about electroceuticals. However, the individual users segment is expected to grow at the highest CAGR during the forecast period (2016-2021).

On the basis of region, the electroceuticals market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. The large share of the North American region can be attributed to the rising prevalence of arrhythmia, growing prevalence of chronic diseases, high prevalence of hearing loss, expected approvals for retinal implants in the U.S., conferences & annual meetings held in the U.S., increasing regulatory approvals in the U.S., increasing burden of cancer and diabetes, and increase in hearing loss owing to rising aging population in Canada. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period (2016-2021).

Source: Organisation for Economic Co-operation and Development (OECD) Publications, The National Center for Biotechnology Information (NCIB), National Institute on Deafness and Other Communication Disorders (NIDCD), Alzheimer’s Association, International Diabetes Federation (IDF), National Institute on Aging (NIA), Heart Rhythm Society, World Heart Federation, Hearing Industries Association (HIA), National Institutes of Health (NIH), Experts Interviews, MnM Analysis

The major players in electroceuticals market include Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Limited (Australia), Sonova Holding AG (Switzerland), LivaNova PLC (U.K.), Biotronik (Germany), Nevro Corporation (U.S.), Second Sight Medical Products, Inc. (U.S.), and ElectroCore LLC (U.S.). Others are BioElectronics Corporation (U.S.), MED-EL (Austria), Cefaly Technology (Belgium), Stimwave LLC (U.S.), Vomaris Innovations, Inc. (U.S.), EnteroMedics Inc. (U.S.), NeuroSigma, Inc. (U.S.), and Oticon Medical (France).

Exteneded Description

"Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) - Global Forecast to 2021"

Electroceuticals are medical devices that use electrical impulses to modulate the body's neural circuits as an alternative to drug-based interventions. These electroceutical devices read and modify electrical signals passing along the nerves of the body, including irregular or altered impulses that can occur in association with a broad range of diseases.

The implantable cardioverter defibrillators segment is expected to account for the largest share of the electroceuticals/bioelectric medicine market, by product, in 2016. Increasing sudden cardiac arrest (SCA) leading to cardiovascular death, technological advancements in ICDs, and increasing arrhythmia is contributing to the large share of this segment. The implantable electroceutical devices segment is expected to account for the largest share of the electroceuticals/bioelectric medicine market, by type of device, in 2016. The rising research in this industry and collaborations and partnerships to development electroceutical devices, these devices providing continuous treatment within the body, and providing an environment for the easy treatment of patients is driving growth in this market segment. The hospitals segment is estimated to account for the largest share of the electroceuticals/bioelectric medicine market, by end user, in 2016. This can be attributed to increasing burden of diseases such as cardiac arrhythmias, Parkinson’s, Alzheimer’s, retinitis pigmentosa, epilepsy, and depression; and increasing awareness about electroceuticals.

North America is expected to account for the largest share of the global electroceuticals/bioelectric medicine market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American region can be attributed to the rising prevalence of arrhythmia, growing prevalence of chronic diseases, expected approvals for retinal implants, increasing regulatory approvals in the U.S., increasing burden of cancer and diabetes, and increase in hearing loss owing to rising aging population in Canada, among others. The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the rising adoption of neurostimulation, increasing cases of diabetes, increasing prevalence of hearing loss, increasing geriatric population, conferences on electroceutical devices, increasing prevalence of Parkinson’s Disease, and regulatory approvals of cochlear implants in the Asia-Pacific region.

The electroceuticals/bioelectric medicine market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, approvals, new product launches, agreements/collaborations/joint ventures/partnerships, marketing and promotion activities, acquisitions and mergers, expansions, market developments, new program launches, and product enhancements) to increase their market shares and establish a stronger foothold in the global market.

Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Limited (Australia), Sonova Holding AG (Switzerland), LivaNova PLC (U.K.), Biotronik (Germany), Nevro Corporation (U.S.), Second Sight Medical Products, Inc. (U.S.), and ElectroCore LLC (U.S.) are the key players in the global electroceuticals/bioelectric medicine market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios of the top players in the medical animation market. The report analyzes the market based on product, type of device, application, and end user

- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the electroceuticals/bioelectric medicine market

- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various electroceuticals/bioelectric medicines across regions

- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the electroceuticals/bioelectric medicine market

Competitive Assessment: In-depth assessment of strategies, products, distribution networks, and manufacturing capabilities of the leading players in the electroceuticals/bioelectric medicine market
Note: Product cover images may vary from those shown
5 of 4
- Biotronik
- Boston Scientific Corporation
- Cochlear Limited
- Electrocore LLC
- Livanova PLC
- Medtronic PLC
- Nevro Corp.
- Second Sight Medical Products, Inc.
- Sonova Holding AG
- St. Jude Medical, Inc.
Note: Product cover images may vary from those shown
6 of 4
Note: Product cover images may vary from those shown
Adroll
adroll